|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,285.00 INR | +0.40% |
|
+1.15% | +12.27% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 01/08 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 642B 6.73B 5.84B 5.46B 4.98B 9.38B 9.54B 64.06B 25.1B 321B 25.28B 24.73B 1,073B | P/E 2026 |
44.2x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 603B 6.32B 5.48B 5.13B 4.68B 8.81B 8.95B 60.14B 23.56B 302B 23.74B 23.22B 1,007B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.74x |
| Free-Float |
51.05% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.40% | ||
| 1 week | +1.15% | ||
| Current month | +2.29% | ||
| 1 month | -0.71% | ||
| 3 months | +1.24% | ||
| 6 months | +12.31% | ||
| Current year | +12.27% |
| 1 week | 2,245 |  | 2,310 |
| 1 month | 2,162 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +1.15% | +11.02% | +186.47% | 6.73B | |
| -0.31% | -0.21% | +19.34% | +70.69% | 48.85B | |
| -2.47% | +3.77% | +55.63% | +121.20% | 41.43B | |
| +0.76% | +7.05% | +25.58% | +87.03% | 12.46B | |
| -0.33% | -0.05% | -4.17% | +18.01% | 12.39B | |
| +1.35% | -0.38% | +30.98% | +136.36% | 9.08B | |
| -0.77% | +6.85% | +23.83% | +39.14% | 7.53B | |
| -0.12% | +5.00% | +40.26% | -12.95% | 7.14B | |
| -1.22% | +4.46% | -25.04% | +29.64% | 5.88B | |
| +1.06% | +2.98% | +31.24% | +103.61% | 4.59B | |
| Average | -0.18% | +3.14% | +20.87% | +77.92% | 15.61B | |
| Weighted average by Cap. | -0.68% | +3.34% | +27.78% | +84.11% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.61B 1.39B 1.3B 1.19B 2.24B 2.27B 15.27B 5.98B 76.64B 6.03B 5.9B 256B | 168B 1.76B 1.53B 1.43B 1.3B 2.45B 2.49B 16.75B 6.56B 84.05B 6.61B 6.47B 280B |
| Net income | 20.53B 215M 187M 175M 159M 300M 305M 2.05B 802M 10.28B 808M 791M 34.28B | 23.11B 242M 210M 197M 179M 338M 343M 2.3B 903M 11.57B 910M 890M 38.59B |
| Net Debt | -39.29B -412M -357M -334M -305M -574M -584M -3.92B -1.54B -19.67B -1.55B -1.51B -65.61B | -14.47B -152M -132M -123M -112M -211M -215M -1.44B -566M -7.24B -570M -557M -24.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | INR 2,285.00 | +0.40% | 448,223 |
| 11/08/26 | INR 2,276.00 | +1.10% | 284,670 |
| 10/08/26 | INR 2,251.30 | -1.22% | 257,787 |
| 07/08/26 | INR 2,279.10 | +0.40% | 437,610 |
| 06/08/26 | INR 2,270.00 | +0.49% | 556,267 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
